skip to main content

Cisplatin Ototoxicity Survivorship — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

HardUrological CancersCisplatin Ototoxicity SurvivorshipSCE Medical Oncology

A 55-year-old man with non-seminomatous germ cell tumour develops cisplatin-related ototoxicity after BEP chemotherapy. He has bilateral high-frequency sensorineural hearing loss. What long-term survivorship issue is this?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DPermanent cumulative cochlear injury requiring formal audiological rehabilitation

Cisplatin causes cumulative, usually irreversible outer-hair-cell injury, so formal audiological assessment and rehabilitation are appropriate. Permanent neural auditory injury requiring central auditory-processing rehabilitation: central processing loss has a different audiological pattern from cisplatin cochleotoxicity. Permanent ossicular injury requiring reconstructive middle-ear surgery: ossicular disease causes conductive rather than high-frequency sensorineural loss. Permanent vestibular injury requiring balance and gaze-stabilisation rehabilitation: vestibular toxicity primarily causes disequilibrium rather than the stated audiogram. Permanent autoimmune cochleitis requiring systemic immunosuppressive treatment: the exposure and bilateral high-frequency pattern favour direct cisplatin injury.

Reference: Cisplatin 1 mg/mL UK summary of product characteristics (Current UK SmPC, accessed July 2026): https://www.medicines.org.uk/emc/product/100546/smpc